July 29, 2020
Guess who’s back
Kodak. Yeah, remember them? It seems the company just got a $765 million government loan under the Defense Production Act to start producing ingredients for generic drugs.
It’s going to create “starter materials” and active pharmaceutical ingredients using its extensive chemical expertise, as part of a long-term plan to reduce U.S. reliance on Chinese ingredients. (https://archive.is/7CEKg)